The Dr. Gabrielle Lyon Show

Is Ozempic Actually Safe? CEO of Major Pharmacy Speaks Out | Shaun Noorian, CEO

17 snips
Apr 22, 2025
In a riveting discussion, Shaun Noorian, engineer and CEO of Empower Pharmacy, dives into the world of compounded GLP-1 medications. He breaks down the legalities and safety concerns surrounding these therapies amid rising pressures from Big Pharma. Shaun highlights why Americans face exorbitant drug prices, sometimes 10 times higher than Europeans, and sheds light on the urgent need for patient advocacy. He passionately advocates for the role of compounding pharmacies in making life-saving medications accessible and affordable to all.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

GLP-1 Price Disparity

  • U.S. consumers pay about 10 times more than Europeans for the same GLP-1 drugs.
  • Pharmaceutical companies reduce prices only after losing market share to compounding pharmacies.
INSIGHT

Compounding vs Big Pharma Pricing

  • Big Pharma sets prices high to maintain monopolies and max profits.
  • Compounding pharmacies focus on affordability by producing medications cheaply and relying on volume.
INSIGHT

Safety of Compounded Medications

  • Compounding pharmacies are heavily regulated and meet strict manufacturing standards.
  • They pose no more danger than Big Pharma, contradicting common misconceptions pushed by pharmaceutical companies.
Get the Snipd Podcast app to discover more snips from this episode
Get the app